The results of a nationwide, multicenter clinical trial provide solid evidence for the use of convalescent plasma as an early treatment for people with COVID-19.
WHO Advises Against Convalescent Plasma as COVID-19 Treatment
The World Health Organization (WHO) late Monday advised against using convalescent plasma to treat COVID-19. “For non-severe COVID-19 patients, WHO recommends against its use, while it should only be used within clinical trials for severe and critical COVID-19 patients,” the WHO announced. Convalescent plasma therapy involves using the blood plasma of patients who recovered from COVID-19…
Results for COVID-19 Convalescent Plasma Still Inconclusive More Than a Year After Emergency Authorization Issued
News Analysis Data on the effectiveness of convalescent plasma for hospitalized COVID-19 patients is still inconclusive despite more than a year since the federal authority first issued an emergency use authorization (EUA) for the therapy and many studies have been conducted. Findings from a recent randomized controlled trial suggest that convalescent plasma—the liquid component of…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta